Title of Collaborative Activity: |
A5295 Evaluation of Xpert Mycobacterium tuberculosis/rifampin (MTB/RIF) Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis (TB) Suspects |
Description of Collaborative Activity: |
This initiative will estimate the sensitivity of a single Xpert Mycobacterium tuberculosis/rifampin (MTB/RIF) assay (performed on sputum) in TB suspects with at least one acid fast bacilli (AFB) sputum smear positive result and at least one culture result positive for Mycobacterium tuberculosis. |
Type of Collaborative Activity: |
Research Initiative
|
Year the Collaborative Activity Originated: |
2010 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID |
HHS Agency Collaborators on this Activity: |
CDC |